Don’t let the high cost of brand concentrated long-acting basal insulin disrupt your diabetes care. We help eligible patients access Toujeo (insulin glargine U-300) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
Toujeo PAP for diabetes patients.
Eligibility verification.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$480/pack | Save substantially |
| CVS Pharmacy | ~$500/pack | Save substantially |
| Walmart | ~$370/pack | Save substantially |
| Costco | ~$360/pack | Save substantially |
Semglee U-100 alt | ~$150/pack | Biosimilar cheaper |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
Semglee U-100 biosimilar (same drug, lower concentration) much cheaper. Medicare $35 cap.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Toujeo:
Still $350–$500/pack per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Toujeo assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Toujeo is U-300 concentrated insulin glargine — slightly longer (>24h), flatter profile than U-100 Lantus. Slightly less hypoglycemia. Same active drug at 3x concentration in smaller volume.
How Toujeo Works:
Higher concentration U-300 forms slower-dissolving depot at injection site — extends action profile beyond 24 hours. Flatter than U-100.
Modest clinical advantage over U-100 in some patients — less nocturnal hypoglycemia in trials. Not always justified by cost difference.
Form and use:
Toujeo SC injection once daily. SoloStar prefilled pen. NOT interchangeable unit-for-unit with U-100 — separate prescription.
Generic availability:
No generic Toujeo. U-100 insulin glargine (Lantus brand, Semglee biosimilar interchangeable, Basaglar, Rezvoglar) — same drug at lower concentration, much cheaper, similar clinical effect for most patients.
Warnings:
Same as other insulin glargine — hypoglycemia, hypokalemia, lipodystrophy.
Toujeo $350–$500. Semglee U-100 ~$150. Medicare $35 cap.
Same drug. Toujeo U-300 concentrated, slightly flatter/longer profile. Modest clinical advantage in some studies (less nocturnal hypoglycemia). Cost difference often not justified — most patients do well on U-100 Lantus/Semglee at much lower cost.
Not interchangeable. If switching, monitor closely — initial dose conversion not 1:1.
Yes since 2023.
Semglee U-100 biosimilar much cheaper. Medicare cap.
Semglee U-100 biosimilar dramatically cheaper. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.